Enhancement of coronary vasodilator action of adenosne by 1,4-Bis-(3-(3,4,5-trimethoxybenzoyl-oxy)-propyl)-perhydro-1,4-diazepine (Dilazep I.N.N.).
D000241:Adenosine / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001381:Azepines / Q000494:pharmacology*; D001565:Benzoates; D003331:Coronary Vessels / Q000187:drug effects*; D004285:Dogs; D004357:Drug Synergism; D006325:Heart Atria; D006439:Hemodynamics / Q000187:drug effects; D007267:Injections; D007275:Injections, Intravenous; D008297:Male; D014665:Vasodilator Agents / Q000494:pharmacology*
D001381:Azepines; D001565:Benzoates; D014665:Vasodilator Agents; D000241:Adenosine